Press Releases
Novo Nordisk expands patient access to authentic, FDA-approved Wegovy® via collaborations with multiple telehealth organizations
All doses of FDA-approved Wegovy®, the most widely prescribed and studied GLP-1 for weight loss, are now accessible to patients of select telehealth providers via simplified pathway to NovoCare® PharmacyProviders
